Total Payments
$3,791
2024 Payments
$585.54
Companies
16
Transactions
36
Medicare Patients
8,990
Medicare Billing
$10.0M
Payment Breakdown by Category
Food & Beverage$3,791 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,791 | 36 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alimera Sciences, Inc. | $719.32 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $595.29 | 5 | $0 (2022) |
| Allergan, Inc. | $499.26 | 5 | $0 (2021) |
| Regeneron Pharmaceuticals, Inc. | $460.80 | 5 | $0 (2024) |
| Genentech USA, Inc. | $312.70 | 3 | $0 (2024) |
| Carl Zeiss Meditec USA, Inc. | $170.11 | 2 | $0 (2024) |
| US Oncology Corporate, Inc. | $138.80 | 1 | $0 (2022) |
| EyePoint Pharmaceuticals US, Inc. | $130.67 | 1 | $0 (2019) |
| Apellis Pharmaceuticals, Inc. | $123.47 | 1 | $0 (2023) |
| Alcon Laboratories Inc | $117.99 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $585.54 | 6 | Carl Zeiss Meditec USA, Inc. ($170.11) |
| 2023 | $454.08 | 5 | Apellis Pharmaceuticals, Inc. ($123.47) |
| 2022 | $509.19 | 4 | US Oncology Corporate, Inc. ($138.80) |
| 2021 | $406.82 | 4 | Regeneron Healthcare Solutions, Inc. ($138.19) |
| 2020 | $137.68 | 2 | Allergan, Inc. ($124.81) |
| 2019 | $615.20 | 5 | Alimera Sciences, Inc. ($243.68) |
| 2018 | $526.79 | 5 | Genentech USA, Inc. ($187.70) |
| 2017 | $556.16 | 5 | Alimera Sciences, Inc. ($228.23) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $128.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/19/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $37.29 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/22/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug), YUTIQ | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 05/30/2024 | Carl Zeiss Meditec USA, Inc. | VERACITY SURGICAL (Device) | Food and Beverage | In-kind items and services | $159.58 | General |
| Category: Eye Care Data Management | ||||||
| 01/16/2024 | Carl Zeiss Meditec USA, Inc. | ARTEVO 800 (Device) | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: Digital Microscope | ||||||
| 08/21/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $116.71 | General |
| 07/28/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $37.79 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/03/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $123.47 | General |
| Category: Ophthalmology | ||||||
| 03/28/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $76.20 | General |
| 02/27/2023 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $99.91 | General |
| Category: Ophthalmology | ||||||
| 11/02/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/22/2022 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $124.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/14/2022 | Bausch & Lomb Americas Inc. | VISUDYNE (Drug) | Food and Beverage | In-kind items and services | $111.05 | General |
| Category: Ophthalmology | ||||||
| 08/22/2022 | US Oncology Corporate, Inc. | — | Food and Beverage | Cash or cash equivalent | $138.80 | General |
| 12/07/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $67.23 | General |
| Category: RETINA | ||||||
| 09/29/2021 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $133.24 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/19/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $68.16 | General |
| Category: RETINA | ||||||
| 07/20/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $138.19 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/10/2020 | PORTOLA PHARMACEUTICALS, LLC | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $12.87 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 01/28/2020 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $124.81 | General |
| Category: RETINA | ||||||
| 10/22/2019 | EyePoint Pharmaceuticals US, Inc. | DEXYCU (Drug) | Food and Beverage | In-kind items and services | $130.67 | General |
| Category: Postoperative Inflammation | ||||||
| 07/16/2019 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $121.84 | General |
| Category: Ophthalmology | ||||||
| 07/16/2019 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $121.84 | General |
| Category: Ophthalmology | ||||||
| 05/31/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $114.79 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,396 | 18,185 | $6.7M | $2.6M |
| 2022 | 13 | 2,125 | 10,520 | $6.2M | $2.4M |
| 2021 | 18 | 2,108 | 8,822 | $6.1M | $2.4M |
| 2020 | 17 | 2,361 | 8,998 | $6.7M | $2.6M |
Total Patients
8,990
Total Services
46,525
Medicare Billing
$10.0M
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 159 | 2,214 | $3.9M | $1.5M | 38.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 82 | 1,634 | $898,700 | $298,757 | 33.2% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 35 | 7,920 | $435,600 | $229,739 | 52.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 547 | 1,805 | $370,025 | $156,645 | 42.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 279 | 1,384 | $426,960 | $135,245 | 31.7% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 37 | 537 | $196,890 | $115,661 | 58.7% |
| 92250 | Photography of the retina | Office | 2023 | 602 | 1,968 | $251,904 | $51,769 | 20.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 210 | 214 | $49,006 | $21,756 | 44.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 173 | 173 | $48,959 | $21,032 | 43.0% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 11 | 11 | $30,800 | $9,696 | 31.5% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 31 | 64 | $8,512 | $4,931 | 57.9% |
| 92242 | Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | Office | 2023 | 23 | 23 | $8,050 | $4,473 | 55.6% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 16 | 22 | $19,690 | $3,912 | 19.9% |
| 92134 | Imaging of retina | Office | 2023 | 100 | 105 | $8,295 | $2,954 | 35.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 16 | 31 | $3,472 | $1,631 | 47.0% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 60 | 61 | $3,660 | $1,153 | 31.5% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 15 | 19 | $3,116 | $700.04 | 22.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 169 | 2,213 | $3.9M | $1.6M | 40.6% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 99 | 2,070 | $1.1M | $455,971 | 40.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 531 | 1,686 | $345,630 | $145,331 | 42.0% |
| 67028 | Injection of drug into eye | Office | 2022 | 277 | 1,263 | $390,930 | $123,532 | 31.6% |
| 92250 | Photography of the retina | Office | 2022 | 574 | 1,801 | $230,421 | $46,524 | 20.2% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 12 | 976 | $53,680 | $29,125 | 54.3% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 199 | 205 | $46,945 | $18,951 | 40.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 115 | 115 | $32,545 | $13,864 | 42.6% |
About Richard Hwang, M.D., PH.D
Richard Hwang, M.D., PH.D is a Ophthalmology healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2010. The National Provider Identifier (NPI) number assigned to this provider is 1548587769.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Richard Hwang, M.D., PH.D has received a total of $3,791 in payments from pharmaceutical and medical device companies, with $585.54 received in 2024. These payments were reported across 36 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,791).
As a Medicare-enrolled provider, Hwang has provided services to 8,990 Medicare beneficiaries, totaling 46,525 services with total Medicare billing of $10.0M. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist, Student in an Organized Health Care Education/Training Program
- Location El Paso, TX
- Active Since 04/28/2010
- Last Updated 06/17/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1548587769
Products in Payments
- EYLEA (Biological) $683.35
- OZURDEX (Drug) $499.26
- Iluvien (Drug) $471.91
- EYLEA AFLIBERCEPT INJECTION (Biological) $207.31
- EYLEA HD (Biological) $165.43
- VERACITY SURGICAL (Device) $159.58
- DEXYCU (Drug) $130.67
- ILUVIEN (Drug) $125.00
- Vabysmo (Drug) $125.00
- Syfovre (Drug) $123.47
- Lucentis (Biological) $119.02
- Constellation (Device) $117.99
- VISUDYNE (Drug) $111.05
- BROLUCIZUMAB (Drug) $106.31
- Cimerli (Biological) $99.91
- ANDEXXA (Biological) $12.87
- ARTEVO 800 (Device) $10.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in El Paso
Mark Gallardo, M.d, M.D
Ophthalmology — Payments: $1.4M
Ophthalmology $1.4M
Dr. David Metrikin, M.d, M.D
Ophthalmology — Payments: $15,500
Ophthalmology $15,500
Dinesh Bahl, Md, MD
Ophthalmology — Payments: $13,825
Ophthalmology $13,825
Dr. Jeremy Cuthbertson, M.d, M.D
Ophthalmology — Payments: $12,937
Ophthalmology $12,937
Dennis Reiter, D.o, D.O
Ophthalmology — Payments: $10,158
Ophthalmology $10,158
Michael Foote, M.d, M.D
Ophthalmology — Payments: $9,192
Ophthalmology $9,192